About this trial
This prospective multi-site observational study aims to describe causes and clinical outcomes of acute febrile illness as well as host biomarkers in patients aged \>28 days residing in rural areas in Laos, Myanmar, Thailand, the Thai-Myanmar border region, and Bangladesh and presenting with acute febrile illnesses (≤ 14 days duration) to participating health facilities.
This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z
Eligibility criteria
Qualifiers
The patient and/or where relevant their parent/guardian/caretaker is willing and able to give informed consent /assent for participation in the study;
Aged > 28 days (day of birth = Day 1);
Axillary temperature at presentation (≥ 37.5°C (99.5°F) OR < 35.5°C (95.9°F)) and no more likely cause than sepsis for hypothermia OR History of fever in the 24 hours prior to presentation;
Onset of illness ≤ 14 days
Disqualifiers
Accident or trauma is the cause for the patient's presentation;
Presentation ≤ 3 days after routine immunisations
Is currently under follow-up or has been afebrile for less than 72 hours after completion of a follow-up period.
The treating healthcare worker's decision is to send the patient home following initial assessment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Oxford
Lead sponsor
Shoklo Malaria Research Unit (SMRU)
Collaborator
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
Collaborator
Building Resources Across Communities (BRAC), Bangladesh
Collaborator
Mahidol Oxford Tropical Medicine Research Unit
Collaborator
Chiang Rai Clinical Research Unit (CCRU), Thailand
Collaborator